D
Enliven Therapeutics, Inc. ELVN
$20.32 $0.3751.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 38.65% 48.52% 57.93% 56.54% 40.72%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 20.30% 23.61% 31.30% 44.94% 68.53%
Operating Income -20.30% -23.61% -31.30% -44.94% -68.53%
Income Before Tax -21.33% -18.84% -24.04% -37.59% -60.23%
Income Tax Expenses -100.00% -- -- -- --
Earnings from Continuing Operations -20.99% -19.14% -24.36% -37.97% -60.68%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -20.99% -19.14% -24.36% -37.97% -60.68%
EBIT -20.30% -23.61% -31.30% -44.94% -68.53%
EBITDA -20.36% -23.69% -31.39% -45.08% -68.77%
EPS Basic -3.52% -0.19% 12.85% 58.72% 73.81%
Normalized Basic EPS -7.29% -6.98% 7.48% 58.58% 74.40%
EPS Diluted -3.52% -0.19% 12.85% 58.72% 73.81%
Normalized Diluted EPS -7.29% -6.98% 7.48% 58.58% 74.40%
Average Basic Shares Outstanding 16.25% 18.82% 32.91% 72.96% 161.08%
Average Diluted Shares Outstanding 16.25% 18.82% 32.91% 72.96% 161.08%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --